These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
59 related articles for article (PubMed ID: 14595251)
1. [Medullary cancers of the thyroid: genetic aspects]. Orgiazzi J Ann Endocrinol (Paris); 2003 Oct; 64(4):345-9. PubMed ID: 14595251 [No Abstract] [Full Text] [Related]
2. The familial medullary thyroid carcinoma-associated RET E768D mutation in a multiple endocrine neoplasia type 2A case. Aiello A; Cioni K; Gobbo M; Collini P; Gullo M; Della Torre G; Passerini E; Ferrando B; Pilotti S; Pierotti MA; Pasini B Surgery; 2005 May; 137(5):574-6. PubMed ID: 15855933 [No Abstract] [Full Text] [Related]
3. RET oncogene mutations in 75 cases of familial medullary thyroid carcinoma in Japan. Kameyama K; Okinaga H; Takami H Biomed Pharmacother; 2004; 58(6-7):345-7. PubMed ID: 15271413 [TBL] [Abstract][Full Text] [Related]
4. Management of patients with hereditary medullary thyroid carcinoma. Fitze G Eur J Pediatr Surg; 2004 Dec; 14(6):375-83. PubMed ID: 15630638 [TBL] [Abstract][Full Text] [Related]
5. Amplification and overexpression of mutant RET in multiple endocrine neoplasia type 2-associated medullary thyroid carcinoma. Huang SC; Torres-Cruz J; Pack SD; Koch CA; Vortmeyer AO; Mannan P; Lubensky IA; Gagel RF; Zhuang Z J Clin Endocrinol Metab; 2003 Jan; 88(1):459-63. PubMed ID: 12519890 [TBL] [Abstract][Full Text] [Related]
6. [Diagnosis and therapy of medullary thyroid carcinoma]. Obara T; Kanbe M; Iihara M; Yamaguchi K; Futami H Nihon Naika Gakkai Zasshi; 1997 Jul; 86(7):1202-8. PubMed ID: 9379100 [No Abstract] [Full Text] [Related]
7. Polymorphisms in the RET proto-oncogene and the phenotypic presentation of familial medullary thyroid carcinoma. Magalhães PK; de Castro M; Elias LL; Soares EG; Maciel LM Thyroid; 2004 Oct; 14(10):848-52. PubMed ID: 15588382 [TBL] [Abstract][Full Text] [Related]
8. The RET IVS1-126G>T variant is strongly associated with the development of sporadic medullary thyroid cancer. Fernandez RM; Robledo M; Antinolo G; Pecina A; Ruiz-Llorente S; Eng C; Borrego S Thyroid; 2004 Apr; 14(4):329-31. PubMed ID: 15142370 [No Abstract] [Full Text] [Related]
9. Genetic testing in endocrinology: lessons learned from experience with multiple endocrine neoplasia type 2 (MEN2). Jimenez C; Gagel RF Growth Horm IGF Res; 2004 Jun; 14 Suppl A():S150-7. PubMed ID: 15135800 [TBL] [Abstract][Full Text] [Related]
11. Lessons learned from the management of a rare genetic cancer. Cote GJ; Gagel RF N Engl J Med; 2003 Oct; 349(16):1566-8. PubMed ID: 14561800 [No Abstract] [Full Text] [Related]
12. Mutations in the RET proto-oncogene in medullary thyroid carcinoma. Höppner W Clin Lab; 2007; 53(5-6):283-4. PubMed ID: 17605402 [No Abstract] [Full Text] [Related]
15. Cost analysis of DNA-based testing in a large Canadian family with multiple endocrine neoplasia type 2. Gilchrist DM; Morrish DW; Bridge PJ; Brown JL Clin Genet; 2004 Oct; 66(4):349-52. PubMed ID: 15355438 [TBL] [Abstract][Full Text] [Related]
16. [Multiple endocrine neoplasia 2A type: a genetic study of one family]. Arias Miranda IM; Casal Alvarez F; Castaño L Med Clin (Barc); 2005 Jan; 124(3):116. PubMed ID: 15710101 [No Abstract] [Full Text] [Related]
17. Description of the first two seemingly unrelated Greek Cypriot families with a common C618R RET proto-oncogene mutation. Neocleous V; Passalaris T; Spanou E; Kitsios P; Skordis N; Deltas CC Genet Test; 2004; 8(2):163-8. PubMed ID: 15345114 [TBL] [Abstract][Full Text] [Related]